How to evaluate three expansion markets for a board deck

Market Entry Assessment: Three Markets for a Board Deck

Put all three markets through the same market entry assessment, scored on five tests: the revenue pool you can serve, its growth driver, entry cost and time, your right to win, and how fast you land a reference customer. Size each on one definition, cite every figure, and recommend a gated order of entry, not a single winner.

What is the board actually deciding?

A board shown three expansion markets is not choosing a country. It is deciding how much capital to commit, in what order, and on what evidence management will stop. A deck that profiles three countries side by side and leaves the choice to the room has done the research and skipped the analysis.

The useful output narrows the options. Three candidates should leave the deck as one market to fund now, one to prepare, and one to hold until a stated condition is met. That gives the board three decisions it can take in a single meeting: approve the first entry, approve the preparation spend for the second, and agree the trigger for the third. A list of country facts is not an argument. The board needs a structured argument with a number behind each step.

This is why the market entry assessment behind the deck has to be built on comparable terms from the first hour. A ranking built from one country's regional estimate and another's national estimate compares two definitions, not two markets, and the first director who came from banking or consulting will find the seam.

The implication for a strategy team of two or three: fix the scoring frame before anyone opens a market report.

Which criteria should every market be scored on?

Five tests carry nearly every expansion decision. They are parallel, so they sit in a table. The weights between them are a judgment, so they belong in the deck's argument, stated before the scores.

The five tests for a three-market comparison
TestWhat it measuresEvidence that holds in a boardroomThe common mistake
Serviceable demandThe revenue pool your offer can address in that country, in one currency and one yearOfficial statistics on population and sector spend, carried through to your segment; commercial trackers as a cross-checkQuoting the headline figure for the whole sector or the whole region
Growth driverWhy the pool grows, and whether that cause lasts the plan periodGovernment strategy documents, budget allocations, regulatory mandatesA growth rate with no named cause
Cost and time to enterEntity setup, licensing, local hiring rules, tax, months to first revenueRegulator, ministry, labor and procurement rulesBlending one-off setup cost into run-rate cost, or leaving it out
Right to winWho holds the buyers today, and where a new entrant can be differentNamed incumbents, their positioning, recent dealsA list of competitors with no gap identified
Time to first reference customerHow soon a referenceable win is realistic, and what it opens up nextProcurement routes, buyer concentration, sales-cycle evidenceYear-one revenue the pipeline cannot support

Write the weights on the slide. A board that sees weights chosen after the ranking will assume they were chosen to produce it. For most B2B entries the heaviest weights belong on serviceable demand and time to first reference customer, because together they decide whether the entry pays back inside the period the board is willing to fund. In the Gulf healthcare business case in the worked example, a six-month delay to the first signed contract would defer cumulative payback by 9 to 12 months, and the analysis named it the single most important downside variable.

Right to win is the test most often done badly. A list of incumbents is description; the finding is where a new entrant can be different and whether buyers will pay for that difference. A competitive landscape built for each country should end on that gap, not on a market-share chart.

How do you make three market sizes comparable?

Comparability breaks in four places: definition, geography, year and currency. Each has to be fixed before a number reaches the comparison slide, and a figure that cannot be fixed stays off it.

Geography is the one that slips most quietly. Ken Research puts Middle East healthcare consulting at $2.409bn in 2025, rising to $4.152bn by 2031 at 9.5% a year; its country coverage includes Israel and Turkey alongside Saudi Arabia, the UAE and Qatar. Mordor Intelligence forecasts healthcare consulting demand in the six GCC states to grow 11.12% a year through 2031, inside a GCC management consulting market of $6.83bn in 2025. The two growth rates do not disagree. They describe different regions, so the Middle East figure is a ceiling for the Gulf, never a Gulf figure, and blending the two produces a number for no market at all. This means every figure on the slide carries its geography, or it does not go on the slide.

Setting two such figures side by side is the same discipline used to reconcile market size estimates that don't match: establish what each one counts before asking which is right.

When trackers disagree, or do not exist, build the pool from official data. The World Bank publishes population and current health spending per person, the latter drawn from the WHO's Global Health Expenditure Database, on one basis for every country. In 2023 health spending per person was $2,402 in the UAE, $1,825 in Saudi Arabia and $1,804 in Qatar. Multiplied by each country's 2023 population, that gives spending pools of about $61.5bn in Saudi Arabia, $25.2bn in the UAE and $4.8bn in Qatar. By population the UAE is 22% of the three-country total; by spending it is 28%. This means a ranking on population alone would understate the UAE by almost a fifth.

22% → 28%

The UAE's share of the Saudi Arabia, UAE and Qatar total: first by population, then by health spending, 2023World Bank population and per-capita health expenditure series (WHO Global Health Expenditure Database); shares computed for this post

An independent source is the cross-check. The US Commercial Service's Saudi healthcare guide, last published May 11, 2026, puts Saudi Arabia at 60% of healthcare expenditure across all six GCC countries. The World Bank arithmetic gives it 67% of a three-country pool that leaves out Kuwait, Oman and Bahrain. Different denominators, consistent answers: the sizing holds.

Smaller markets often have no published figure at their level at all. The pool then has to be built from spending, buyer counts and price points, the approach used to size a market no published report covers, and the deck says plainly that the number was built rather than found.

Where does evidence a board will accept come from?

The order of preference is fixed: official statistics first, then government strategy, budgets and regulation, then commercial trackers labeled as directional. For a US company the natural first stop is the Country Commercial Guide for each market, prepared at US embassies by Commerce Department, State Department and other agency staff, and covering market conditions, opportunities, regulations and business customs.

Read the underlying document, not only the summary. The same Saudi healthcare guide gives the private sector's contribution as rising from 25% to 35% by 2030 in one passage and from 40% to 65% by 2030 in another, and states the base for neither. A slide that quotes either will be asked what it is a share of, and the answer has to come from the Saudi strategy document itself.

Consistency matters as much as quality. The general rules for finding market data you can cite apply country by country; what changes in a three-market deck is that every country needs the same tier of source. One market sized from a ministry and another from a vendor press release reads as unequal confidence, and the board will discount the weaker one whether or not it is wrong.

Commercial trackers still earn a place, as a range check. The Gulf healthcare business case anchored its sizing on official expenditure, population and national strategy data, and labeled the consulting trackers directional.

How should the deck turn three scores into a decision?

Rank, then sequence, then gate. The ranking says where the economics are best. The sequence says what the company can execute with the people and capital it has. The gate says what must be true before the next market receives money.

  1. The recommendation and the ask: which market first, the capital requested and the period it covers.
  2. The comparison: all three markets scored on the same five tests, with the weights stated.
  3. The serviceable pool in each market, on one definition, one year and one currency, with every source named.
  4. The cost of entry, with one-off setup separated from run-rate cost, and the months to first revenue.
  5. The sequence and the entry mode for each market: a controlled local entity, a partner, or coverage from a regional hub.
  6. The gates: the evidence required before the second market is funded, and the condition that slows or stops the program.
  7. The sensitivities: the two or three assumptions that move payback most, and the response if each goes wrong.

Entry mode belongs inside the comparison, not after it. A market that only works through a local subsidiary competes with the first market for the same senior hires; a market that can be served from a hub does not. That difference often settles the order more decisively than the market sizes.

Separate setup cost from run-rate cost on the slide. Blended together, entry costs make a healthy delivery model look unattractive in year one, and the board rejects the right market for the wrong reason.

Stop conditions make the ask easier to approve. Name the leading indicators in advance and the response if they miss. In the Gulf case they were qualified pipeline coverage, average realized price and time from entity setup to first signed contract, with hiring slowed if any of the three underperformed for two consecutive quarters. This means the board approves a bounded commitment with a defined exit, not an open-ended one.

Worked example

Gulf healthcare: Saudi Arabia, the UAE and Qatar, ranked and sequenced for a board

Caspr's business case for a consulting firm entering Gulf healthcare, prepared for August 25, 2026, evaluated Saudi Arabia, the UAE and Qatar for a board. It sized the three from official data first: 2025 populations of 36.97 million, 11.51 million and 2.97 million, and a Saudi health-sector contribution to GDP that the Ministry of Health projects will grow by about 60% between 2020 and 2030. Two consulting trackers, $2.409bn in 2025 growing 9.5% a year and an 11.12% annual growth rate for GCC healthcare consulting, served as directional benchmarks only; the first, on its publisher's page, covers the wider Middle East. The analysis did not crown a winner. It gave each market a role: Saudi Arabia as the scale anchor, entered through a wholly controlled Riyadh entity; the UAE as the premium specialist market, built in parallel from a Dubai front end with Abu Dhabi coverage; Qatar served from Riyadh or Dubai, with a permanent office only once mandates repeat. The revenue build follows the roles: Saudi Arabia 55% to 65% of revenue in years one to three, the UAE 25% to 35%, Qatar and the wider Gulf 5% to 15% by year three, a split that tracks the 67%, 28% and 5% shares of health spending, tilted toward the UAE's higher-yield work. In the base case revenue reaches $3.3m, $6.8m and $10.5m over three years against a year-one cost envelope of $4.2m to $5.0m, with break-even in year two and a year-three EBITDA margin of 14% to 18%. A six-month delay to the first signed contract defers payback by 9 to 12 months, the largest single downside. The board ask was correspondingly narrow: fund 18 to 24 months of ramp-up through four gates (establish, validate, scale, regionalize), and authorize Qatar only after Saudi Arabia and the UAE produce referenceable work.

The published figures

PublisherFigurePeriodWhat it countsPublishedLast verified
Ken Research 2.409 (USD billion) 2025 Middle East healthcare consulting services market value; country coverage includes Saudi Arabia, the UAE, Qatar, Israel and Turkey; forecast $4.152bn by 2031 at 9.5% CAGR August 2026 (page date) October 17, 2026
Mordor Intelligence 11.12 (% CAGR) through 2031 Healthcare consulting demand growth within the GCC management consulting market (six GCC states) 2026-01-20 (page last updated) October 17, 2026
Mordor Intelligence 6.83 (USD billion) 2025 GCC management consulting services market, all sectors; forecast $8.97bn by 2031 at 4.64% CAGR 2026-01-20 (page last updated) October 17, 2026
International Trade Administration (US Commercial Service) 60 (% of healthcare expenditure) Current (guide last published 2026) Saudi Arabia's share of healthcare expenditure across all six GCC countries May 11, 2026 October 17, 2026
World Bank (WHO Global Health Expenditure Database) 67 (% of health spending) 2023 Saudi Arabia's share of current health expenditure across Saudi Arabia, the UAE and Qatar only: population multiplied by per-capita spend, computed for this post 2026-10-08 (data last updated) October 17, 2026

Why the figures differ

  • definitional Ken Research (9.5% CAGR, Middle East healthcare consulting) and Mordor Intelligence (11.12% CAGR, GCC healthcare consulting) Ken Research's coverage includes Israel and Turkey; Mordor's is the six GCC states. Different markets, so neither corrects the other.
  • definitional International Trade Administration (Saudi Arabia 60% of GCC healthcare expenditure) and the World Bank-derived share (67% of three-country spending) Six GCC countries against three: leaving out Kuwait, Oman and Bahrain raises Saudi Arabia's share, so the two figures are consistent.

How the depths compare

Saudi ArabiaUnited Arab EmiratesQatar
Role in the sequenceScale anchor, entered firstPremium specialist market, built in parallelSecond phase, served from a hub
Population, 202536.97M11.51M2.97M
Health spending per person, 2023$1,825$2,402$1,804
Health spending pool, 2023 (derived)$61.5bn$25.2bn$4.8bn
Best-fit workTransformation PMO, cluster corporatization, PPP readinessDigital health, payer-provider analytics, regulatory advisoryStrategy execution, prevention, digital enablement, financing
Entry modeWholly controlled Riyadh entityDirect entity, Dubai front end with Abu Dhabi coverageHub-and-spoke from Riyadh or Dubai
Key constraintSaudization and local-content weighting in public tendersRegulation split across federal, Dubai and Abu Dhabi authoritiesSmaller client pool, concentrated procurement
Share of revenue, years 1 to 355% to 65%25% to 35%5% to 15% by year 3, with the wider Gulf

Frequently asked

What is a market entry assessment?

A market entry assessment tells you whether to enter a specific country or segment, and how. You size the demand you can serve, name what drives growth, cost the entry and map who holds the buyers today. Then you end with a recommendation on entry mode, sequence and the conditions for going ahead.

How do you compare market entry into several Southeast Asian countries?

Compare Southeast Asian markets by putting every country through one frame: the same segment definition, base year and currency. Use official statistics first and commercial trackers as cross-checks. Score each country on serviceable demand, growth driver, entry cost, right to win and time to first customer, then propose an order of entry, not a single pick.

Should the deck recommend one market or rank all three?

Rank all three markets in the deck, then recommend a sequence. A board funds an order of entry with conditions more readily than a single bet. A ranking alone hides the constraint that usually sets the order: the people and capital the first market absorbs. So name what must be true before the second market gets funded.

How should a startup research a new country market?

Start with the customer you already sell to, then find its equivalent in the new country market: how many such buyers exist, what they spend and who serves them now. Use government statistics and the US Commercial Service's Country Commercial Guide before paid reports. Win a first local customer before you commit headcount.

How do you build a market entry recommendation for a case competition?

Build a case competition market entry recommendation as you'd build one for a board, since judges reward the same discipline. Apply one frame to every market, cite each figure to a named source, and state the order of entry and the mode. Spend most of your time on the recommendation and its risks, not on country profiles.

Keep reading